Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001)

P. Chalela; E. Munoz; D. Inupakutika; S. Kaghyan; D. Akopian; V. Kaklamani; K. Lathrop; A. Ramirez

doi:10.1016/j.conctc.2019.100349

Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001)

P. Chalela, E. Munoz, D. Inupakutika, S. Kaghyan, D. Akopian, V. Kaklamani, K. Lathrop, A. Ramirez

Producción científica: Comment/debate › revisión exhaustiva

2 Citas (Scopus)

Resumen

The authors regret to inform that we will not be using the MMAS-4 scale to assess medication adherence as originally planned and included in our protocol manuscript, due to the high cost of the training required to use the instrument and potential legal issues with MMAS Research LLC. We will assess the patients’ medication adherence by using 3 questions created by the research team. The authors would like to apologise for any inconvenience caused.

Idioma original	English (US)
Número de artículo	100349
Publicación	Contemporary Clinical Trials Communications
Volumen	14
DOI	https://doi.org/10.1016/j.conctc.2019.100349
Estado	Published - jun 2019

ASJC Scopus subject areas

Pharmacology

Acceder al documento

10.1016/j.conctc.2019.100349

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001)'. En conjunto forman una huella única.

Citar esto

Chalela, P., Munoz, E., Inupakutika, D., Kaghyan, S., Akopian, D., Kaklamani, V., Lathrop, K., & Ramirez, A. (2019). Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001). Contemporary Clinical Trials Communications, 14, Artículo 100349. https://doi.org/10.1016/j.conctc.2019.100349

Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001). / Chalela, P.; Munoz, E.; Inupakutika, D. et al.
En: Contemporary Clinical Trials Communications, Vol. 14, 100349, 06.2019.

Producción científica: Comment/debate › revisión exhaustiva

Chalela, P, Munoz, E, Inupakutika, D, Kaghyan, S, Akopian, D, Kaklamani, V , Lathrop, K & Ramirez, A 2019, 'Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001)', Contemporary Clinical Trials Communications, vol. 14, 100349. https://doi.org/10.1016/j.conctc.2019.100349

Chalela P, Munoz E, Inupakutika D, Kaghyan S, Akopian D, Kaklamani V et al. Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001). Contemporary Clinical Trials Communications. 2019 jun;14:100349. doi: 10.1016/j.conctc.2019.100349

@article{f10e1860f7334d6abf24834cfb2410d1,

title = "Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001)",

abstract = "The authors regret to inform that we will not be using the MMAS-4 scale to assess medication adherence as originally planned and included in our protocol manuscript, due to the high cost of the training required to use the instrument and potential legal issues with MMAS Research LLC. We will assess the patients{\textquoteright} medication adherence by using 3 questions created by the research team. The authors would like to apologise for any inconvenience caused.",

author = "P. Chalela and E. Munoz and D. Inupakutika and S. Kaghyan and D. Akopian and V. Kaklamani and K. Lathrop and A. Ramirez",

note = "Publisher Copyright: {\textcopyright} 2019",

year = "2019",

month = jun,

doi = "10.1016/j.conctc.2019.100349",

language = "English (US)",

volume = "14",

journal = "Contemporary Clinical Trials Communications",

issn = "2451-8654",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Corrigendum to “Improving adherence to endocrine hormonal therapy among breast cancer patients

T2 - Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 12 (2018) 109-115](S2451865418300784)(10.1016/j.conctc.2018.10.001)

AU - Chalela, P.

AU - Munoz, E.

AU - Inupakutika, D.

AU - Kaghyan, S.

AU - Akopian, D.

AU - Kaklamani, V.

AU - Lathrop, K.

AU - Ramirez, A.

PY - 2019/6

Y1 - 2019/6

N2 - The authors regret to inform that we will not be using the MMAS-4 scale to assess medication adherence as originally planned and included in our protocol manuscript, due to the high cost of the training required to use the instrument and potential legal issues with MMAS Research LLC. We will assess the patients’ medication adherence by using 3 questions created by the research team. The authors would like to apologise for any inconvenience caused.

AB - The authors regret to inform that we will not be using the MMAS-4 scale to assess medication adherence as originally planned and included in our protocol manuscript, due to the high cost of the training required to use the instrument and potential legal issues with MMAS Research LLC. We will assess the patients’ medication adherence by using 3 questions created by the research team. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85063380343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063380343&partnerID=8YFLogxK

U2 - 10.1016/j.conctc.2019.100349

DO - 10.1016/j.conctc.2019.100349

M3 - Comment/debate

C2 - 31049460

AN - SCOPUS:85063380343

SN - 2451-8654

VL - 14

JO - Contemporary Clinical Trials Communications

JF - Contemporary Clinical Trials Communications

M1 - 100349

ER -